ID
33048
Beschrijving
This form contains a form to document the randomisation number, investigational products and the pharmacokinetics. To be assessed at the visits V1-3. Study ID: 103629 Clinical Study ID: TRX103629 Study Title: An open-label, randomized, 3-period crossover study to evaluate sumatriptan and naproxen pharmacokinetics for a combination tablet product containing sumatriptan/naproxen sodium followed by IMITREX™ (sumatriptan succinate) Injection 4mg administered using the IMITREX STATdose System and a sumatriptan/naproxen sodium tablet followed by IMITREX (sumatriptan succinate) Injection 6mg administered using the STATdose system compared with an IMITREX tablet 100mg followed by an IMITREX tablet 100mg Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00875784 Clinicaltrials.gov link: https://clinicaltrials.gov/ct2/show/NCT00875784 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran; Imitrex,Imiject,Imigran Study Indication: Migraine Disorders
Link
https://clinicaltrials.gov/ct2/show/NCT00875784
Trefwoorden
Versies (3)
- 18-11-18 18-11-18 -
- 25-11-18 25-11-18 -
- 25-11-18 25-11-18 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
25 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Sumatriptan pharmacokinetics for TREXIMA/IMITREX NCT00875784
Randomisation Number, Investigational Products, Pharmacokinetics Blood
Beschrijving
Randomisation Number (Only Visit 1)
Alias
- UMLS CUI-1
- C1300638
- UMLS CUI-2
- C0034656
Beschrijving
Subject's randomisation
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1300638
- UMLS CUI [1,2]
- C0034656
Beschrijving
Randomisation number
Datatype
text
Alias
- UMLS CUI [1,1]
- C1300638
- UMLS CUI [1,2]
- C0034656
Beschrijving
Date of randomisation
Datatype
date
Alias
- UMLS CUI [1]
- C0034656
Beschrijving
Investigational Product
Alias
- UMLS CUI-1
- C0304229
Beschrijving
Treatment Confirmation
Alias
- UMLS CUI-1
- C0750484
- UMLS CUI-2
- C0087111
Beschrijving
Receivement of the correct treatment
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0750484
- UMLS CUI [1,2]
- C0087111
Beschrijving
Reason(s) in case the subject did not receive the correct treatment
Datatype
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C3827420
- UMLS CUI [1,3]
- C0392360
Beschrijving
Dosing Date and Time
Alias
- UMLS CUI-1
- C0178602
- UMLS CUI-2
- C1264639
Beschrijving
Pharmacokinetics Blood
Alias
- UMLS CUI-1
- C0031328
- UMLS CUI-2
- C0005767
Beschrijving
Planned relative time of blood sample collection for pharmacokinetics analysis
Datatype
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005834
Beschrijving
To be assessed for all timepoints up to 4 hours post-dose (included)
Datatype
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005834
Beschrijving
To be assessed for all timepoints from 6 hours post-dose on (included).
Datatype
datetime
Alias
- UMLS CUI [1,1]
- C1264639
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005834
Similar models
Randomisation Number, Investigational Products, Pharmacokinetics Blood
C0034656 (UMLS CUI-2)
C0034656 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,2])
C0087111 (UMLS CUI-2)
C0087111 (UMLS CUI [1,2])
C3827420 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C1264639 (UMLS CUI [1,2])
C0005767 (UMLS CUI-2)
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])